Robert Chess - Director, Nektar Therapeutics

As of September 24, 2021


Robert Chess Net Worth

  • Net worth is estimated to be at least $28.41M
  • Owns at least 281,973 units of Nektar Therapeutics stock
  • Sold an estimated value of $17.97M in the last 18 years at Nektar Therapeutics

Robert Chess Trading

  • Largest purchase of shares was 29,500 units , worth over $449.58K on December 31, 2014
  • Largest sale of shares was 25,000 units , worth over $2.3M on April 9, 2018
  • In total has made about 62 transactions over 18 years
  • Usually trades in September, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Nektar Therapeutics Insider Trading

  • The most recent transaction was 24,149 units sold on November 18, 2021 by Gil Labrucherie worth over $316.39K
  • In the last 18 years, insiders at Nektar Therapeutics sold an estimated value of $293.47M and bought an estimated value of $84.98M
  • The most active traders are Gil Labrucherie, SVP,  Howard Robin, President & CEO,  and Robert Chess, Director
  • Insider trading is most common in September, with the busiest year in 2017 and 2016

NEKTAR THERAPEUTICS Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1